Blanket Purchase Agreement 140G0218A0004

This Blanket Purchase Agreement (BPA) contract was awarded by the Department of Health and Human Services, National Institutes of Health to prime contractor Lonza LLC, a global partner to the pharmaceutical and specialty chemicals markets. The BPA is for the procurement of laboratory supplies and chemicals, with no set-aside designations. The contract has a total ceiling value of $0, as it represents an open-ended ordering mechanism rather than a fixed-value award. Task orders under the BPA...

This Blanket Purchase Agreement (BPA) was awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Proteintech Group, Inc., a minority-owned, small disadvantaged business. The BPA has a ceiling value of $1,000,000.00 and a period of performance through August 31, 2024. The BPA is for the procurement of BIOLOGICAL MATERIALS. While the specific details of the required products and services are not provided, a BPA is a type of Indefinite Delivery Vehicle that allows...

This Blanket Purchase Agreement (BPA) was awarded by the Office of Logistics and Acquisition Operations, a civilian federal agency, to Bruker Spatial Biology, Inc., a for-profit manufacturer of goods. The single-award BPA has a ceiling value of $10,000,000.00 and a period of performance through October 31, 2025. The BPA is for the procurement of operation and maintenance items only, specifically biological materials, chemicals, and laboratory supplies. The broad scope and lack of set-asides...

The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a single-award Blanket Purchase Agreement (BPA) to Worthington Biochemical Corp, a for-profit manufacturing organization. This indefinite delivery vehicle (IDV) contract, with a potential value of $0.00, aims to procure a variety of biological materials, blood/blood products, chemicals, and laboratory supplies. The BPA was awarded on April 24, 2015 and has a last order...

This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Nephron Sterile Compounding Center LLC on March 1, 2020, with a potential value of $2.5 million. The BPA is for specialized compounded intravenous solutions with no set-aside used. The period of performance extends through the last date to order of September 30, 2023. The BPA facilitates recurring orders for specific pharmaceutical products and supplies, including Phenylephrine HCI Injection,...

This Blanket Purchase Agreement (BPA) was awarded by a U.S. federal government agency to Atofina Chemicals Incorporated, the prime contractor. The BPA, with a ceiling value of $1, was awarded on April 9, 1999 and has an ultimate completion date of August 22, 2002. The contract is categorized as "OTHER THAN SCHEDULE", indicating it is not associated with a pre-defined GSA Schedule. The scope and purpose of this BPA is not clearly defined in the provided information. Without additional...

The Blanket Purchase Agreement (BPA) identified by the contract IDV HHSN263201400058B was awarded by the Office of Logistics and Acquisition Operations, a civilian federal agency, to the prime contractor Spectrum Laboratory Products, Inc. (doing business as Spectrum Chemicals & Laboratory Products Inc.). The contract has a period of performance through September 30, 2024 and is a single award with no set-aside designation. The BPA is primarily for the procurement of chemicals, laboratory...

BioMarin Pharmaceutical Inc., a for-profit pharmaceutical manufacturer, was awarded a single-award Blanket Purchase Agreement (BPA) by the Department of Veterans Affairs (VA) under GSA Schedule 61-IB for Pharmaceuticals and Drugs. The $151,685 BPA has a potential value over $3 million and will run through October 2024, facilitating the VA's procurement of the drug Palynziq (pegvaliase-pqpz) to treat phenylketonuria in adult patients. Under this BPA, the VA has issued a $117,376.50 firm...

This Blanket Purchase Agreement (BPA) is a single-award federal contract indefinite delivery vehicle (IDV) awarded by the Office of Logistics and Acquisition Operations, a civilian federal agency, to Adipogen Corporation. The contract has a ceiling value of $50,000,000.00 and a period of performance through December 31, 2025. The BPA is intended to procure O/M (operations and maintenance) items, specifically biological materials and chemicals, in support of the President's Department of...

The Blanket Purchase Agreement (BPA) is a federal contract indefinite delivery vehicle (IDV) awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Genzyme Corporation, doing business as Sanofi Genzyme. The BPA has a ceiling value of $3,000,000 and a period of performance from June 6, 2024 to June 5, 2026. The purpose of the BPA is to provide the VA with a streamlined contracting method to procure specialty pharmaceutical products,...